July 5, 2018

ViAqua develops a particle-based matrix for delivering antiviral medication to shrimp 

Nutreco announces today that it has invested in Israeli startup ViAqua as part of its focus on combatting disease in the aquaculture industry. ViAqua is developing the first orally-ad...

June 8, 2018

The Israel-based company develops eye drops intended to alleviate farsightedness caused by aging 

Orasis Pharmaceuticals LTD., a privately-held, clinical-stage pharmaceutical company focused on developing an innovative eye drop for the treatment of presbyopia symptoms,...

Please reload

Blog Archive 

Please reload

Tags

Please reload

Follow

©2018 by Lanta Capital Holdings. Proudly created with Wix.com